PLT Health Solutions Launches Trust-Building Initiative
The new program focuses on ingredient integrity, quality control, sustainability, and efficacy.
Photo © iStockphoto.com/StudioThreeDots
Ingredients supplier PLT Health Solutions (Morristown, NJ) has rolled out a new “transparency and trust-building initiative” that it believes will allow its customers to add value to their brands and stand out on the market. The initiative, called PLT360, focuses on ingredient integrity and quality compliance, as well as sustainability and efficacy.
“PLT360 is a recognition that ‘best-in-class’ ingredient solutions go beyond the demands for traceability, ingredient identification, and quality compliance,” says Devin Stagg, vice president of strategy and business development, PLT Health Solutions. “They must also be efficacious and sustainable.”
Stagg adds that “the program is designed to create a new type of value for consumers and as a way to differentiate ingredients that build brands and win market share.”
In terms of ingredient integrity, PLT360 involves source traceability, a baseline safety analysis, chemical and physical identification processes, and verification of important qualifiers such as GMO or organic. The quality compliance aspect of the program entails meeting goals for international quality assurance and compliance standards that may be priorities for PLT’s customers.
The third pillar of PLT360, sustainability, is all about harvesting, manufacturing, and delivering an ingredient with consideration for the environment and the lives of people involved in its production. The efficacy aspect of the program involves delivering the most positive consumer experience on top of high levels of efficacy, as well as enhancing the ability of PLT’s customers to “translate research into commercially significant value statements for consumers.”
PLT says it began the PLT360 ingredient review process for some of its ingredients this summer and will continue the review through 2016.
Read more:
FDA Under Fire for Role in Lawsuit between GNC and Oregon Attorney General
The Dietary Supplements Industry Won the Bayer Case, but Still Needs to Watch the FTC, Leaders Warn
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Gencor to distribute Gnosis by Lesaffre’s Landkind Pure Salidroside in the United States
September 11th 2024The ingredient is manufactured by Gnosis by Lesaffre as an alternative to rhodiola extract. Salidroside is the most studied bioactive in rhodiola, to which the extract efficacy is attributed to.
New review from BAPP estimates adulteration of five popular botanicals
September 10th 2024The study focused on the adulteration of black cohosh rhizome, echinacea root or herb, elder berry, ginkgo leaf, and turmeric root/rhizome. The authors reviewed 78 publications with a total of 2995 samples. Of the 2995 samples, 818 were reported to be adulterated or mislabeled.
